APC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
4 reviews
Product Citations
publications
53-6dot7_APC_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • 53-6dot7_APC_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
See APC spectral data
Cat # Size Price Quantity Avail. Save
100711 25 µg $30
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100712 100 µg $95
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions. The solution is free of unconjugated APC and unconjugated antibody.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, and immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 μm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
Product Citations
  1. Medyouf H, et al. 2010. Blood. 115:1175. PubMed
  2. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  3. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  4. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  5. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  6. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  7. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  8. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  9. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  10. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  11. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  12. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  13. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  14. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  15. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  16. Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed
  17. Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed
  18. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  19. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  20. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  21. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  22. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  23. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  24. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  25. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  26. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  27. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  28. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  29. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  30. Chatterjee S, et al. 2018. Cell Metab. 27:85. PubMed
  31. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  32. Solanki A, et al. 2018. Development. 145. PubMed
  33. Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed
  34. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  35. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  36. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  37. Lee JS 2018. Cell. 174:1559. PubMed
  38. Hou Y 2018. Immunity. 49:490. PubMed
  39. Gaya M 2018. Cell. 172:517. PubMed
  40. Nakamura K 2018. Cancer cell. 33:634. PubMed
  41. Johnson JL 2018. Immunity. 48:243. PubMed
  42. Smith LK 2018. Immunity. 48:299. PubMed
  43. Cong J 2018. Cell metabolism. 28:243. PubMed
  44. Wang D 2018. Immunity. 48:659. PubMed
  45. Chen S, et al. 2018. Cell Rep. 25:1729. PubMed
  46. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  47. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  48. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  49. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  50. Hayatsu N, et al. 2017. Immunity. 47:268. PubMed
  51. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  52. Koliaraki V, et al. 2019. Cell Rep. 26:536. PubMed
  53. Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed
  54. Liu J, et al. 2019. J Exp Med. 216:656. PubMed
  55. Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed
  56. Miska J, et al. 2019. Cell Rep. 27:226. PubMed
  57. Misumi I, et al. 2019. Cell Rep. 27:514. PubMed
  58. Misumi I, et al. 2019. Cell Rep. 27:1387. PubMed
  59. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  60. Luo Y, et al. 2019. Cell Rep. 26:1869. PubMed
  61. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  62. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  63. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  64. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  65. Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed
Publication Library
RRID
AB_312750 (BioLegend Cat. No. 100711)
AB_312751 (BioLegend Cat. No. 100712)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 01/21/2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account